869557-43-7Relevant articles and documents
FORMULATIONS OF AZAINDOLE COMPOUNDS
-
Paragraph 0301-0303, (2021/01/22)
The present invention relates to pharmaceutical compositions, each comprising a multitude of granules that make up an intragranular phase of the composition, wherein the granules are produced by fluid bed granulation and comprise a HCI salt of Compound (1
METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION
-
Paragraph 0251; 0252; 0253, (2016/12/01)
A method of preparing a compound of Formula (I) or a pharmaceutically acceptable salt thereof comprises: (a) reacting Compound (1) or (b) a pharmaceutically acceptable salt thereof with Compound (2) in the presence of water, an organic solvent, a base, an
INHIBITORS OF INFLUENZA VIRUSES REPLICATION
-
Paragraph 0179-0181, (2015/06/03)
Polymorphic forms of Compound (1) or a pharmaceutically acceptable salt thereof, wherein Compound (1) is represented by the following structural formula: are Form A of HCl salt of Compound (1)·1/2Η20, Form F of HCl salt of Compound (1)·3Η2